HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oral Care, Topical Product 'Natural' Claims Paint Bullseye For Class Action

This article was originally published in The Rose Sheet

Executive Summary

Class action complaints alleging misleading "natural" claims for food products have been stayed pending completion of FDA's look at whether it should formally define the term for use in food, but there is no parallel FDA consideration of how the term is used for oral care products and topicals.

You may also be interested in...



2016 In Review: ‘Free Of’ Claims, Ingredient Snafus Breed Controversy

Undeclared ingredient use by Ava Anderson Non Toxic and the presence of sodium lauryl sulfate in Honest Company products, contrary to its “free of” claims, led to the former’s collapse and class action litigation against the latter in 2016. Meanwhile, “natural” marketing continues to be a risky business, with FTC stepping up enforcement action last year and efforts underway to promote clearer legal standards.

Tom's Of Maine Appealing NAD-Advised Name Change For Naturally Dry Antiperspirant

Tom's of Maine's Naturally Dry Antiperspirant represents a misleading natural claim given that the product’s active wetness-control ingredient is an extensively processed aluminum salt, NAD says, siding with challenger Unilever. Colgate will appeal the decision, arguing that the claims at issue are subject to a 2015 court order and therefore the dispute falls outside of NAD’s jurisdiction.

FTC Action Against 'All Natural' Claims Likely To 'Embolden' Plaintiffs

Attorneys agree that FTC's announced settlements with personal-care companies for misleading "all-natural" claims likely will not be helpful to class-action defendants making primary-jurisdiction arguments and could actually spur more litigation, similar to trends following FDA warning letters.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108670

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel